 | • レポートコード：GIR-105X20111 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、全身性経口アゾールのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。全身性経口アゾールの種類別市場規模（フルコナゾール、イトラコナゾール、ポサコナゾール）、用途別市場規模（消化管カンジダ症、泌尿生殖器カンジダ症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・全身性経口アゾールの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis AG、Pfizer, Inc、Sanofi-Aventis、Merck & Co., Inc、Enzon Pharmaceuticals, Inc、Bayer AG、Astellas Pharma, Inc、GlaxoSmithKline plc、Abbott ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：フルコナゾール、イトラコナゾール、ポサコナゾール ・用途別分析2016年-2026年：消化管カンジダ症、泌尿生殖器カンジダ症、その他 ・全身性経口アゾールの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・全身性経口アゾールのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・全身性経口アゾールのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・全身性経口アゾールの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・全身性経口アゾールの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Systemic Oral Azoles market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Systemic Oral Azoles size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Systemic Oral Azoles market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Systemic Oral Azoles market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fluconazole
Itraconazole
Posaconazole
Market segment by Application can be divided into
Gastrointestinal Candidiasis
Genitourinary Tract Candidiasis
Other
The key market players for global Systemic Oral Azoles market are listed below:
Novartis AG
Pfizer, Inc
Sanofi-Aventis
Merck & Co., Inc
Enzon Pharmaceuticals, Inc
Bayer AG
Astellas Pharma, Inc
GlaxoSmithKline plc
Abbott
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Systemic Oral Azoles Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Systemic Oral Azoles Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Fluconazole
1.2.3 Itraconazole
1.2.4 Posaconazole
1.3 Market Analysis by Application
1.3.1 Overview: Global Systemic Oral Azoles Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Gastrointestinal Candidiasis
1.3.3 Genitourinary Tract Candidiasis
1.3.4 Other
1.4 Global Systemic Oral Azoles Market Size & Forecast
1.4.1 Global Systemic Oral Azoles Sales in Value (2016-2026))
1.4.2 Global Systemic Oral Azoles Sales in Volume (2016-2026)
1.4.3 Global Systemic Oral Azoles Price by Type (2016-2026) & (USD/Unit)
1.5 Global Systemic Oral Azoles Production Capacity Analysis
1.5.1 Global Systemic Oral Azoles Total Production Capacity (2016-2026)
1.5.2 Global Systemic Oral Azoles Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Systemic Oral Azoles Market Drivers
1.6.2 Systemic Oral Azoles Market Restraints
1.6.3 Systemic Oral Azoles Trends Analysis
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Systemic Oral Azoles Product and Services
2.1.4 Novartis AG Systemic Oral Azoles Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer, Inc
2.2.1 Pfizer, Inc Details
2.2.2 Pfizer, Inc Major Business
2.2.3 Pfizer, Inc Systemic Oral Azoles Product and Services
2.2.4 Pfizer, Inc Systemic Oral Azoles Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sanofi-Aventis
2.3.1 Sanofi-Aventis Details
2.3.2 Sanofi-Aventis Major Business
2.3.3 Sanofi-Aventis Systemic Oral Azoles Product and Services
2.3.4 Sanofi-Aventis Systemic Oral Azoles Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Merck & Co., Inc
2.4.1 Merck & Co., Inc Details
2.4.2 Merck & Co., Inc Major Business
2.4.3 Merck & Co., Inc Systemic Oral Azoles Product and Services
2.4.4 Merck & Co., Inc Systemic Oral Azoles Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Enzon Pharmaceuticals, Inc
2.5.1 Enzon Pharmaceuticals, Inc Details
2.5.2 Enzon Pharmaceuticals, Inc Major Business
2.5.3 Enzon Pharmaceuticals, Inc Systemic Oral Azoles Product and Services
2.5.4 Enzon Pharmaceuticals, Inc Systemic Oral Azoles Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Bayer AG
2.6.1 Bayer AG Details
2.6.2 Bayer AG Major Business
2.6.3 Bayer AG Systemic Oral Azoles Product and Services
2.6.4 Bayer AG Systemic Oral Azoles Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Astellas Pharma, Inc
2.7.1 Astellas Pharma, Inc Details
2.7.2 Astellas Pharma, Inc Major Business
2.7.3 Astellas Pharma, Inc Systemic Oral Azoles Product and Services
2.7.4 Astellas Pharma, Inc Systemic Oral Azoles Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 GlaxoSmithKline plc
2.8.1 GlaxoSmithKline plc Details
2.8.2 GlaxoSmithKline plc Major Business
2.8.3 GlaxoSmithKline plc Systemic Oral Azoles Product and Services
2.8.4 GlaxoSmithKline plc Systemic Oral Azoles Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Systemic Oral Azoles Product and Services
2.9.4 Abbott Systemic Oral Azoles Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Systemic Oral Azoles Sales by Manufacturer
3.1 Global Systemic Oral Azoles Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Systemic Oral Azoles Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Systemic Oral Azoles
3.4 Market Concentration Rate
3.4.1 Top 3 Systemic Oral Azoles Manufacturer Market Share
3.4.2 Top 6 Systemic Oral Azoles Manufacturer Market Share
3.5 Global Systemic Oral Azoles Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Systemic Oral Azoles Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Systemic Oral Azoles Market Size by Region
4.1.1 Global Systemic Oral Azoles Sales in Volume by Region (2016-2026)
4.1.2 Global Systemic Oral Azoles Revenue by Region (2016-2026)
4.2 North America Systemic Oral Azoles Revenue (2016-2026)
4.3 Europe Systemic Oral Azoles Revenue (2016-2026)
4.4 Asia-Pacific Systemic Oral Azoles Revenue (2016-2026)
4.5 South America Systemic Oral Azoles Revenue (2016-2026)
4.6 Middle East and Africa Systemic Oral Azoles Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Systemic Oral Azoles Sales in Volume by Type (2016-2026)
5.2 Global Systemic Oral Azoles Revenue by Type (2016-2026)
5.3 Global Systemic Oral Azoles Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Systemic Oral Azoles Sales in Volume by Application (2016-2026)
6.2 Global Systemic Oral Azoles Revenue by Application (2016-2026)
6.3 Global Systemic Oral Azoles Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Systemic Oral Azoles Sales by Type (2016-2026)
7.2 North America Systemic Oral Azoles Sales by Application (2016-2026)
7.3 North America Systemic Oral Azoles Market Size by Country
7.3.1 North America Systemic Oral Azoles Sales in Volume by Country (2016-2026)
7.3.2 North America Systemic Oral Azoles Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Systemic Oral Azoles Sales by Type (2016-2026)
8.2 Europe Systemic Oral Azoles Sales by Application (2016-2026)
8.3 Europe Systemic Oral Azoles Market Size by Country
8.3.1 Europe Systemic Oral Azoles Sales in Volume by Country (2016-2026)
8.3.2 Europe Systemic Oral Azoles Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Systemic Oral Azoles Sales by Type (2016-2026)
9.2 Asia-Pacific Systemic Oral Azoles Sales by Application (2016-2026)
9.3 Asia-Pacific Systemic Oral Azoles Market Size by Region
9.3.1 Asia-Pacific Systemic Oral Azoles Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Systemic Oral Azoles Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Systemic Oral Azoles Sales by Type (2016-2026)
10.2 South America Systemic Oral Azoles Sales by Application (2016-2026)
10.3 South America Systemic Oral Azoles Market Size by Country
10.3.1 South America Systemic Oral Azoles Sales in Volume by Country (2016-2026)
10.3.2 South America Systemic Oral Azoles Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Systemic Oral Azoles Sales by Type (2016-2026)
11.2 Middle East & Africa Systemic Oral Azoles Sales by Application (2016-2026)
11.3 Middle East & Africa Systemic Oral Azoles Market Size by Country
11.3.1 Middle East & Africa Systemic Oral Azoles Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Systemic Oral Azoles Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Systemic Oral Azoles Typical Distributors
12.3 Systemic Oral Azoles Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Systemic Oral Azoles Revenue by Type, (USD Million), 2021-2026
Table 2. Global Systemic Oral Azoles Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Systemic Oral Azoles Product and Services
Table 6. Novartis AG Systemic Oral Azoles Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer, Inc Major Business
Table 9. Pfizer, Inc Systemic Oral Azoles Product and Services
Table 10. Pfizer, Inc Systemic Oral Azoles Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi-Aventis Major Business
Table 13. Sanofi-Aventis Systemic Oral Azoles Product and Services
Table 14. Sanofi-Aventis Systemic Oral Azoles Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 16. Merck & Co., Inc Major Business
Table 17. Merck & Co., Inc Systemic Oral Azoles Product and Services
Table 18. Merck & Co., Inc Systemic Oral Azoles Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Enzon Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 20. Enzon Pharmaceuticals, Inc Major Business
Table 21. Enzon Pharmaceuticals, Inc Systemic Oral Azoles Product and Services
Table 22. Enzon Pharmaceuticals, Inc Systemic Oral Azoles Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 24. Bayer AG Major Business
Table 25. Bayer AG Systemic Oral Azoles Product and Services
Table 26. Bayer AG Systemic Oral Azoles Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Astellas Pharma, Inc Basic Information, Manufacturing Base and Competitors
Table 28. Astellas Pharma, Inc Major Business
Table 29. Astellas Pharma, Inc Systemic Oral Azoles Product and Services
Table 30. Astellas Pharma, Inc Systemic Oral Azoles Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 32. GlaxoSmithKline plc Major Business
Table 33. GlaxoSmithKline plc Systemic Oral Azoles Product and Services
Table 34. GlaxoSmithKline plc Systemic Oral Azoles Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Abbott Basic Information, Manufacturing Base and Competitors
Table 36. Abbott Major Business
Table 37. Abbott Systemic Oral Azoles Product and Services
Table 38. Abbott Systemic Oral Azoles Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Systemic Oral Azoles Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Systemic Oral Azoles Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Systemic Oral Azoles, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Systemic Oral Azoles Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Systemic Oral Azoles Production Site of Key Manufacturer
Table 44. Global Systemic Oral Azoles Sales by Region (2016-2021e) & (K Units)
Table 45. Global Systemic Oral Azoles Sales by Region (2021-2026) & (K Units)
Table 46. Global Systemic Oral Azoles Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Systemic Oral Azoles Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Systemic Oral Azoles Sales by Type (2016-2021e) & (K Units)
Table 49. Global Systemic Oral Azoles Sales by Type (2021-2026) & (K Units)
Table 50. Global Systemic Oral Azoles Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Systemic Oral Azoles Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Systemic Oral Azoles Price by Type (2016-2021e) & (USD/Unit)
Table 53. Global Systemic Oral Azoles Price by Type (2021-2026) & (USD/Unit)
Table 54. Global Systemic Oral Azoles Sales by Application (2016-2021e) & (K Units)
Table 55. Global Systemic Oral Azoles Sales by Application (2021-2026) & (K Units)
Table 56. Global Systemic Oral Azoles Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Systemic Oral Azoles Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Systemic Oral Azoles Price by Application (2016-2021e) & (USD/Unit)
Table 59. Global Systemic Oral Azoles Price by Application (2021-2026) & (USD/Unit)
Table 60. North America Systemic Oral Azoles Sales by Country (2016-2021e) & (K Units)
Table 61. North America Systemic Oral Azoles Sales by Country (2021-2026) & (K Units)
Table 62. North America Systemic Oral Azoles Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Systemic Oral Azoles Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Systemic Oral Azoles Sales by Type (2016-2021e) & (K Units)
Table 65. North America Systemic Oral Azoles Sales by Type (2021-2026) & (K Units)
Table 66. North America Systemic Oral Azoles Sales by Application (2016-2021e) & (K Units)
Table 67. North America Systemic Oral Azoles Sales by Application (2021-2026) & (K Units)
Table 68. Europe Systemic Oral Azoles Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Systemic Oral Azoles Sales by Country (2021-2026) & (K Units)
Table 70. Europe Systemic Oral Azoles Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Systemic Oral Azoles Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Systemic Oral Azoles Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Systemic Oral Azoles Sales by Type (2021-2026) & (K Units)
Table 74. Europe Systemic Oral Azoles Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Systemic Oral Azoles Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Systemic Oral Azoles Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Systemic Oral Azoles Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Systemic Oral Azoles Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Systemic Oral Azoles Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Systemic Oral Azoles Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Systemic Oral Azoles Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Systemic Oral Azoles Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Systemic Oral Azoles Sales by Application (2021-2026) & (K Units)
Table 84. South America Systemic Oral Azoles Sales by Country (2016-2021e) & (K Units)
Table 85. South America Systemic Oral Azoles Sales by Country (2021-2026) & (K Units)
Table 86. South America Systemic Oral Azoles Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Systemic Oral Azoles Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Systemic Oral Azoles Sales by Type (2016-2021e) & (K Units)
Table 89. South America Systemic Oral Azoles Sales by Type (2021-2026) & (K Units)
Table 90. South America Systemic Oral Azoles Sales by Application (2016-2021e) & (K Units)
Table 91. South America Systemic Oral Azoles Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Systemic Oral Azoles Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Systemic Oral Azoles Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Systemic Oral Azoles Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Systemic Oral Azoles Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Systemic Oral Azoles Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Systemic Oral Azoles Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Systemic Oral Azoles Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Systemic Oral Azoles Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Systemic Oral Azoles Typical Distributors
Table 103. Systemic Oral Azoles Typical Customers
List of Figures
Figure 1. Systemic Oral Azoles Picture
Figure 2. Global Systemic Oral Azoles Sales Market Share by Type in 2020
Figure 3. Fluconazole
Figure 4. Itraconazole
Figure 5. Posaconazole
Figure 6. Global Systemic Oral Azoles Sales Market Share by Application in 2020
Figure 7. Gastrointestinal Candidiasis
Figure 8. Genitourinary Tract Candidiasis
Figure 9. Other
Figure 10. Global Systemic Oral Azoles Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Systemic Oral Azoles Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Systemic Oral Azoles Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Systemic Oral Azoles Sales (2016-2026) & (K Units)
Figure 32. Global Systemic Oral Azoles Production Capacity (2016-2026) & (K Units)
Figure 33. Global Systemic Oral Azoles Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Systemic Oral Azoles Market Drivers
Figure 35. Systemic Oral Azoles Market Restraints
Figure 36. Systemic Oral Azoles Market Trends
Figure 37. Global Systemic Oral Azoles Sales Market Share by Manufacturer in 2020
Figure 38. Global Systemic Oral Azoles Revenue Market Share by Manufacturer in 2020
Figure 39. Systemic Oral Azoles Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Systemic Oral Azoles Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Systemic Oral Azoles Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Systemic Oral Azoles Sales Market Share by Region (2016-2026)
Figure 43. Global Systemic Oral Azoles Revenue Market Share by Region (2016-2026)
Figure 44. North America Systemic Oral Azoles Revenue (2016-2026) & (USD Million)
Figure 45. Europe Systemic Oral Azoles Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Systemic Oral Azoles Revenue (2016-2026) & (USD Million)
Figure 47. South America Systemic Oral Azoles Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Systemic Oral Azoles Revenue (2016-2026) & (USD Million)
Figure 49. Global Systemic Oral Azoles Sales Market Share by Type (2016-2026)
Figure 50. Global Systemic Oral Azoles Revenue Market Share by Type (2016-2026)
Figure 51. Global Systemic Oral Azoles Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Systemic Oral Azoles Sales Market Share by Application (2016-2026)
Figure 53. Global Systemic Oral Azoles Revenue Market Share by Application (2016-2026)
Figure 54. Global Systemic Oral Azoles Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Systemic Oral Azoles Sales Market Share by Country (2016-2026)
Figure 56. North America Systemic Oral Azoles Revenue Market Share by Country (2016-2026)
Figure 57. North America Systemic Oral Azoles Sales Market Share by Type (2016-2026)
Figure 58. North America Systemic Oral Azoles Sales Market Share by Application (2016-2026)
Figure 59. Europe Systemic Oral Azoles Sales Market Share by Country (2016-2026)
Figure 60. Europe Systemic Oral Azoles Revenue Market Share by Country (2016-2026)
Figure 61. Europe Systemic Oral Azoles Sales Market Share by Type (2016-2026)
Figure 62. Europe Systemic Oral Azoles Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Systemic Oral Azoles Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Systemic Oral Azoles Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Systemic Oral Azoles Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Systemic Oral Azoles Sales Market Share by Application (2016-2026)
Figure 67. South America Systemic Oral Azoles Sales Market Share by Country (2016-2026)
Figure 68. South America Systemic Oral Azoles Revenue Market Share by Country (2016-2026)
Figure 69. South America Systemic Oral Azoles Sales Market Share by Type (2016-2026)
Figure 70. South America Systemic Oral Azoles Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Systemic Oral Azoles Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Systemic Oral Azoles Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Systemic Oral Azoles Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Systemic Oral Azoles Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
全身性乾癬治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcoho…- 全身性エリテマトーデス（SLE）薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 SLE is the most common form of lupus and is also called lupus. It is a chronic, autoimmune disease with signs and symptoms that can last for six months or for many years. It can affect any part of the body, such as the skin, joints, and organs (LFA, 2012). SLE occurs when the immune system produces …
- 全身性自己免疫疾患診断の世界市場2018-2025 The Systemic Autoimmune Disease Diagnostics market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size fo…
- 抗真菌薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 An antifungal medication, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others. Scope of the Report: This…
- メトトレキサート薬口径の世界市場2018-2025 Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions.In 2018, the global Methotrexate Oral Solution market size was xx million US$ and is forecast to…